Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach

Aniek J. G. Even; Olga Hamming-Vrieze; Wouter van Elmpt; Veronique J. L. Winnepenninckx; Jolien Heukelom; Margot E. T. Tesselaar; Wouter V. Vogel; Ann Hoeben; Catharina M. L. Zegers; Danielle J. Vugts; Guus A. M. S. van Dongen; Harry Bartelink; Felix M. Mottaghy; Frank Hoebers; Philippe Lambin

doi:10.18632/oncotarget.13910

Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach

Aniek J. G. Even^*, Olga Hamming-Vrieze, Wouter van Elmpt, Veronique J. L. Winnepenninckx, Jolien Heukelom, Margot E. T. Tesselaar, Wouter V. Vogel, Ann Hoeben, Catharina M. L. Zegers, Danielle J. Vugts, Guus A. M. S. van Dongen, Harry Bartelink, Felix M. Mottaghy, Frank Hoebers, Philippe Lambin

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	3870-3880
Number of pages	11
Journal	Oncotarget
Volume	8
Issue number	3
DOIs	https://doi.org/10.18632/oncotarget.13910
Publication status	Published - 17 Jan 2017

Keywords

immuno-PET
Zirconium-89
cetuximab
LAHNSCC
EGFR
GROWTH-FACTOR RECEPTOR
CELL LUNG-CANCER
EGFR EXPRESSION
MACH-NC
CHEMOTHERAPY
SURVIVAL
RADIOTHERAPY
ZR-89
IMMUNOHISTOCHEMISTRY
METAANALYSIS

Access to Document

10.18632/oncotarget.13910

Cite this

Even, A. J. G., Hamming-Vrieze, O., van Elmpt, W., Winnepenninckx, V. J. L., Heukelom, J., Tesselaar, M. E. T., Vogel, W. V., Hoeben, A., Zegers, C. M. L., Vugts, D. J., van Dongen, G. A. M. S., Bartelink, H., Mottaghy, F. M., Hoebers, F., & Lambin, P. (2017). Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach. Oncotarget, 8(3), 3870-3880. https://doi.org/10.18632/oncotarget.13910

Even, Aniek J. G. ; Hamming-Vrieze, Olga ; van Elmpt, Wouter ; Winnepenninckx, Veronique J. L. ; Heukelom, Jolien ; Tesselaar, Margot E. T. ; Vogel, Wouter V. ; Hoeben, Ann ; Zegers, Catharina M. L. ; Vugts, Danielle J. ; van Dongen, Guus A. M. S. ; Bartelink, Harry ; Mottaghy, Felix M. ; Hoebers, Frank ; Lambin, Philippe. / Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer : a theragnostic approach. In: Oncotarget. 2017 ; Vol. 8, No. 3. pp. 3870-3880.

@article{1dd69978bd704b3faf1323ba728bcb04,

title = "Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach",

keywords = "immuno-PET, Zirconium-89, cetuximab, LAHNSCC, EGFR, GROWTH-FACTOR RECEPTOR, CELL LUNG-CANCER, EGFR EXPRESSION, MACH-NC, CHEMOTHERAPY, SURVIVAL, RADIOTHERAPY, ZR-89, IMMUNOHISTOCHEMISTRY, METAANALYSIS",

author = "Even, {Aniek J. G.} and Olga Hamming-Vrieze and {van Elmpt}, Wouter and Winnepenninckx, {Veronique J. L.} and Jolien Heukelom and Tesselaar, {Margot E. T.} and Vogel, {Wouter V.} and Ann Hoeben and Zegers, {Catharina M. L.} and Vugts, {Danielle J.} and {van Dongen}, {Guus A. M. S.} and Harry Bartelink and Mottaghy, {Felix M.} and Frank Hoebers and Philippe Lambin",

year = "2017",

month = jan,

day = "17",

doi = "10.18632/oncotarget.13910",

language = "English",

volume = "8",

pages = "3870--3880",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "3",

}

Even, AJG, Hamming-Vrieze, O, van Elmpt, W , Winnepenninckx, VJL, Heukelom, J, Tesselaar, MET, Vogel, WV, Hoeben, A , Zegers, CML, Vugts, DJ, van Dongen, GAMS, Bartelink, H, Mottaghy, FM , Hoebers, F & Lambin, P 2017, 'Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach', Oncotarget, vol. 8, no. 3, pp. 3870-3880. https://doi.org/10.18632/oncotarget.13910

Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer : a theragnostic approach. / Even, Aniek J. G.; Hamming-Vrieze, Olga; van Elmpt, Wouter ; Winnepenninckx, Veronique J. L.; Heukelom, Jolien; Tesselaar, Margot E. T.; Vogel, Wouter V.; Hoeben, Ann ; Zegers, Catharina M. L.; Vugts, Danielle J.; van Dongen, Guus A. M. S.; Bartelink, Harry; Mottaghy, Felix M.; Hoebers, Frank ; Lambin, Philippe.

In: Oncotarget, Vol. 8, No. 3, 17.01.2017, p. 3870-3880.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer

T2 - a theragnostic approach

AU - Even, Aniek J. G.

AU - Hamming-Vrieze, Olga

AU - van Elmpt, Wouter

AU - Winnepenninckx, Veronique J. L.

AU - Heukelom, Jolien

AU - Tesselaar, Margot E. T.

AU - Vogel, Wouter V.

AU - Hoeben, Ann

AU - Zegers, Catharina M. L.

AU - Vugts, Danielle J.

AU - van Dongen, Guus A. M. S.

AU - Bartelink, Harry

AU - Mottaghy, Felix M.

AU - Hoebers, Frank

AU - Lambin, Philippe

PY - 2017/1/17

Y1 - 2017/1/17

KW - immuno-PET

KW - Zirconium-89

KW - cetuximab

KW - LAHNSCC

KW - EGFR

KW - GROWTH-FACTOR RECEPTOR

KW - CELL LUNG-CANCER

KW - EGFR EXPRESSION

KW - MACH-NC

KW - CHEMOTHERAPY

KW - SURVIVAL

KW - RADIOTHERAPY

KW - ZR-89

KW - IMMUNOHISTOCHEMISTRY

KW - METAANALYSIS

U2 - 10.18632/oncotarget.13910

DO - 10.18632/oncotarget.13910

M3 - Article

VL - 8

SP - 3870

EP - 3880

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 3

ER -